malexander 4 Report post Posted April 9 (edited) I wonder what you can tell us about the recent report of 700 deaths associated with this new drug. Is the risk of death any greater with Nuplazid than with the older anti-psychotics. I feel some responsibility for allowing Acadia Pharmaceuticals access to a large support group to direct market their drug via a contracted speaker. Edited April 12 by malexander clarification of my question Share this post Link to post Share on other sites
Dr. Okun 424 Report post Posted April 14 Almost all antipsychotics have attached to them an increase in mortality. We wrote about this in JAMA Neurology as there is a significant risk of not treating someone with psychosis. Each doctor and each patient need to discuss the risk/benefit and make a decision that feels comfortable. Over the years we have used antipsychotics (clozapine, seroquel, and Nuplazid) very successfully and they have enhanced quality of life in our outpatient population. These drugs do carry a small extra risk and this requires discussion. Hope that helps. Share this post Link to post Share on other sites
